Preview

Бюллетень сибирской медицины

Расширенный поиск

Роль лизосомальных цистеиновых протеиназ в опухолевой прогрессии

https://doi.org/10.20538/1682-0363-2009-2-85-90

Полный текст:

Аннотация

Рассматриваeтся роль лизосомальных цистеиновых протеаз в опухолевой прогрессии. Подробно aнализируется значимость катепсинов в процессах клеточной пролиферации, апоптоза, ангиогенеза, инвазии и метастазирования раковых клеток. Особое внимание уделено обсуждению молекулярных механизмов участия катепсинов в отдельных этапах раковой прогрессии, включающих протеолитическую деградацию компонентов внеклеточного матрикса, активацию предшественников сериновых протеаз и плазминогена. Более того, катепсины стромальных клеток также принимают участие в процессах раковой прогрессии и формирования метастаз и могут являться потенциальными мишенями для противораковой терапии.

Об авторах

М. С. Коровин
Сибирский государственный медицинский университет
Россия

Коровин Матвей Сергеевич, аспирант кафедры патофизиологии 

8-913-825-6977



В. В. Новицкий
Сибирский государственный медицинский университет
Россия
д р мед наук профессор академик РАМН зав кафедрой патофизиологии


О. С. Васильева
Институт имени И. Стефана
Словения
канд мед наук


Список литературы

1. Aggarwal B.B. Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB//Ann. Rheum. Dis. 2000. V. 59. P. 6-16.

2. Aicher A., Zeiher A.M., Dimmeler S. Mobilizing endothelial progenitor cells//Hypertension. 2005. V. 45. № 3. P. 321-325.

3. Barrett A.J. Cellular proteolysis. An overview//Ann. N. Y. Acad. Sci. 1992. V. 674. P. 1-15.

4. Baskin-Bey E.S., Canbay A., Bronk S.F. et al. Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury//Am. J. Physiol. Gastrointest. Liver Physiol. 2005. V. 288. № 2. P. 396-402.

5. Bradham C.A., Qian T., Streetz K. et al. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release//Mol. Cell Biol. 1998. V. 18. № 11. P. 6353-6364.

6. Bröker L.E., Huisman C., Span S.W. et al. Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells//Cancer Res. 2004. V. 64. № 1. Р. 27-30.

7. Carmeliet P. Angiogenesis in health and disease//Nat. Med. 2004. V. 9. P. 653-660.

8. Castiglioni T., Merino M.J., Elsner B. et al. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer//Hum Pathol. 1994. V. 25. P. 857-862.

9. Cavallo-Medved D., Dosescu J., Linebaugh B.E. et al. Mutant K-ras regulates cathepsin B localization in caveolae of human colorectal carcinoma cells//Neoplasia. 2003. V. 5. P. 507-519.

10. Cirman T., Oresic K., Mazovec G.D. et al. Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins//J. Biol. Chem. 2004. V. 279. P. 3578-3587.

11. Coussens L.M., Werb Z. Inflammation and cancer//Nature. 2002. V. 420. P. 860-867.

12. Del Rosso M., Fibbi G., Pucci M. et al. Multiple pathways of cell invasion are regulated by multiple families of serine proteases//Clin. Exp. Metastasis. 2002. V. 19. № 3. P. 193-207.

13. Deussing J., Kouadio M., Rehman S. et al. Identification and characterization of a dense cluster of placenta-specific cysteine peptidase genes and related genes on mouse chromosome 13//Genomics. 2002. V. 79. № 2. P. 225-240.

14. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression//Nat. Rev. Cancer. 2002. V. 2. № 3. P. 161-174.

15. Fehrenbacher N., Jaattela M. Fehrenbacher N Lysosomes as Targets for Cancer Therapy//Cancer Res. 2005. V. 65. № 8. P. 2993-2995.

16. Felbor U., Dreier L., Bryant R.A. et al. Secreted cathepsin L generates endostatin from collagen XVIII // http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Olsen%20BR%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus EMBO J. 2000. V. 19. № 6. P. 1187-1194.

17. Fernandez P.L., Farre X., Nadal A. et al. Expression of cathepsins B and S in the progression of prostate carcinoma//Int. J. Cancer. 2001. V. 95. P. 51-55.

18. Folkman J. Role of angiogenesis in tumor growth and metastasis//Semin Oncol. 2002. V. 29. № 6. P. 15-18.

19. Friedrichs B., Tepel C., Reinheckel T. et al. Thyroid functions of mouse cathepsins B, K, and L//J. Clin. Invest. 2003. V. 111. № 11. P. 1733-1745.

20. Gocheva V., Zeng W., Ke D. et al. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis//Genes Dev. 2006. V. 20. № 5. P. 543-556.

21. Goulet B., Baruch A., Moon N.S. et al. A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor//Mol. Cell. 2004. V. 14. № 2. P. 207-219.

22. Guicciardi M.E., Leist M., Gores G.J. Lysosomes in cell death//Oncogene. 2004. V. 23. № 16. P. 2881-2890.

23. Im E., Venkatakrishnan A., Kazlauskas A. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells//Mol. Biol. Cell. 2005. V. 16. № 8. P. 3488-3500.

24. Isabelle M., Sloane B.F. Cysteine proteases and tumor progression//Perspectives in Drug Discovery and Design. 1995. V. 2. № 3. P. 16-19.

25. Johansson A.C., Steen H., Ollinger K., Roberg K. Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine//Cell. Death. Differ. 2003. V. 10. № 11. P. 1253-1259.

26. Joyce J.A., Baruch A., Chehade K. et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis//Cancer Cell. 2004. V. 5. № 5. P. 443-453.

27. Kobayashi N., Moniwa H., Sugimura M. et al. Effects of membrane-associated cathepsin B on the activation of receptor-bound prourokinase and subsequent invasion of reconstituted basement membranes//Biochim. Biophys. Acta. 1993. V. 1178. P. 55-62.

28. Kruszewski W.J., Rzepko R., Wojtacki J. et al. Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma//Neoplasma. 2004. V. 51. P. 38-43.

29. Lah T.T., Durán Alonso M.B., van Noorden C.J. Antiprotease therapy in cancer: hot or not?//Expert Opin. Biol. Ther. 2006. V. 6. № 3. P. 257-279.

30. Linebaugh B.E., Sameni M., Day N.A. et al. Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass//Eur. J. Biochem. 1999. V. 264. P. 100-109.

31. Marten K., Bremer C., Khazaie K. et al. Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice//Gastroenterology. 2002. V. 122. P. 406-414.

32. Murphy G., Stanton H., Cowell S. et al. Mechanisms for pro matrix metalloproteinase activation//Apmis. 1999. V. 107. P. 38-44.

33. Nagai A., Terashima M., Harada T. et al. Cathepsin B and H activities and cystatin C concentrations in cerebrospinal fluid from patients with leptomeningeal metastasis//Clin. Chim. Acta. 2003. V. 329. № 1-2. P. 53-60.

34. Ortega N., Werb Z. New functional roles for non-collagenous domains of basement membrane collagens//J. Cell Sci. 2002. V. 115. № 22. P. 4201-4214.

35. Potts W., Bowyer J., Jones H. et al. Cathepsin L-deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy//Int. J. Exp. Pathol. 2004. V. 85. № 2. P. 85-96.

36. Rawlings N.D., O'Brien E., Barrett A.J. MEROPS: the protease database/N.D. Rawlings,//Nucleic Acids Res. 2002. V. 30. № 1. P. 343-364.

37. Reiners J.J., Caruso J.A., Mathieu P. et al. Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage//Cell. Death. Differ. 2002. V. 9. № 9. P. 934-944.

38. Roshy S., Sloane B.F., Moin K. Pericellular cathepsin B and malignant progression//Cancer Metastasis Rev. 2003. V. 22. № 2-3. P. 271-286.

39. Ryschich E., Lizdenis P., Ittrich C. et al. Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma//Cancer Res. 2006. V. 66. № 1. P. 198-211.

40. Sinha A.A., Jamuar M.P., Wilson M.J. et al. Plasma membrane association of cathepsin B in human prostate cancer: biochemical and immunogold electron microscopic analysis//Prostate. 2001. V. 49. № 3. P. 172-184.

41. Skrzydlewska E., Sulkowska M., Koda M., Sulkowski S. Proteolytic-antiproteolytic balance and its regulation in carcinogenesis//World J. Gastroenterol. 2005. V. 11. № 9. P. 1251-1266.

42. Sloane B.F., Yan S., Podgorski I. et al. Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment//Semin. Cancer Biol. 2005. V. 15. № 2. P. 149-157.

43. Stoka V., Turk B., Schendel S.L. et al. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route//J. Biol. Chem. 2001. V. 276. Р. 3149-3157.

44. Stubbs M., McSheehy P.M., Griffiths J.R., Bashford C.L. Causes and consequences of tumour acidity and implications for treatment//Mol. Med. Today. 2000. V. 6. № 1. P. 15-19.

45. Turk V., Kos J., Turk B. Cysteine cathepsins (proteases) -on the main stage of cancer?//Cancer. Cell. 2004. V. 5. № 5. P. 409-410.

46. Urbich C., Heeschen C., Aicher A. et al. Cathepsin L is required for endothelial progenitor cell-induced neovascularization // http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Dimmeler%20S%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus Nat. Med. 2005. V. 11. № 2. P. 206-213.

47. Van der Stappen J.W., Williams A.C., Maciewicz R.A., Paraskeva C. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D//Int. J. Cancer. 1996. V. 67. № 4. P. 547-554.

48. Vasiljeva O., Papazoglou A., Kruger A. et al. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer//Cancer Res. 2006. V. 66. № 10. P. 5242-5250.

49. Vasiljeva O., Reinheckel T., Peters C. et al. Emerging roles of cysteine cathepsins in disease and their potential as drug targets//Curr. Pharm. Des. 2007. V. 13. № 4. P.387-403.

50. Yanamandra N., Gumidyala K.V., Waldron K.G. et al. Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis//Oncogene. 2004. V. 23. P. 2224-2230.

51. Yan S., Sloane B.F. Molecular regulation of human cathepsin B: implication in pathologies//Biol. Chem. 2003. V. 384. № 6. P. 845-854.

52. Yeung B.H., Huang D.C., Sinicrope F.A. PS-341 (bortezomib) induces lysosomal cathepsin B release and a caspase-2-dependent mitochondrial permeabilization and apoptosis in human pancreatic cancer cells//J. Biol. Chem. 2006. V. 281. № 17. P. 11923-11932.


Для цитирования:


Коровин М.С., Новицкий В.В., Васильева О.С. Роль лизосомальных цистеиновых протеиназ в опухолевой прогрессии. Бюллетень сибирской медицины. 2009;8(2):85-90. https://doi.org/10.20538/1682-0363-2009-2-85-90

For citation:


Korovin M.S., Novitsky V.V., Vasiliyeva O.S. The role of lysosomal cysteine proteases in tumor progression. Bulletin of Siberian Medicine. 2009;8(2):85-90. (In Russ.) https://doi.org/10.20538/1682-0363-2009-2-85-90

Просмотров: 35


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1682-0363 (Print)
ISSN 1819-3684 (Online)